Strain identifier

BacDive ID: 5765

Type strain: Yes

Species: Fusobacterium nucleatum

Strain Designation: 1612A

Strain history: CIP <- 1984, ATCC <- W.E.C. Moore: strain VPI 4355 <- A.R. Prévot, Inst. Pasteur, Paris, France: strain 1612A

NCBI tax ID(s): 190304 (strain), 851 (species)

For citation purpose refer to the digital object identifier (doi) of the current version.
Archive
version 8.1 (current version):
version 8:
version 7.1:
version 7:
version 6:
version 5:
version 4.1:
version 4:
version 3:
version 2.1:
version 2:
version 1:
version 8.1 (current version)

General

@ref: 6013

BacDive-ID: 5765

DSM-Number: 15643

keywords: genome sequence, 16S sequence, Bacteria, anaerobe, mesophilic, Gram-negative

description: Fusobacterium nucleatum 1612A is an anaerobe, mesophilic, Gram-negative bacterium that was isolated from cervico-facial lesion.

NCBI tax id

NCBI tax idMatching level
851species
190304strain

strain history

@refhistory
6013<- J. Tang, ATCC <- W. E. C. Moore <- A. Prevot
67770Tokyo Med. Dent. Univ. <-- Tama Biochem. Co., Ltd. <-- ATCC 25586 <-- W. E. C. Moore VPI 4355 <-- A. Prévot 1210.
121367CIP <- 1984, ATCC <- W.E.C. Moore: strain VPI 4355 <- A.R. Prévot, Inst. Pasteur, Paris, France: strain 1612A

doi: 10.13145/bacdive5765.20230509.8.1

Name and taxonomic classification

LPSN

  • @ref: 20215
  • description: domain/bacteria
  • keyword: phylum/fusobacteriota
  • domain: Bacteria
  • phylum: Fusobacteriota
  • class: Fusobacteriia
  • order: Fusobacteriales
  • family: Fusobacteriaceae
  • genus: Fusobacterium
  • species: Fusobacterium nucleatum
  • full scientific name: Fusobacterium nucleatum Knorr 1922 (Approved Lists 1980)

@ref: 6013

domain: Bacteria

phylum: Fusobacteria

class: Fusobacteriia

order: Fusobacteriales

family: Fusobacteriaceae

genus: Fusobacterium

species: Fusobacterium nucleatum subsp. nucleatum

full scientific name: Fusobacterium nucleatum subsp. nucleatum (Knorr 1922) Dzink et al. 1990

strain designation: 1612A

type strain: yes

Morphology

cell morphology

@refgram stainconfidencecell shapemotility
69480negative99.75
121367negativerod-shapedno

colony morphology

@refincubation period
60131-2 days
121367

Culture and growth conditions

culture medium

@refnamegrowthlinkcomposition
6013COLUMBIA BLOOD MEDIUM (DSMZ Medium 693)yeshttps://mediadive.dsmz.de/medium/693Name: COLUMBIA BLOOD MEDIUM (DSMZ Medium 693) Composition: Defibrinated sheep blood 50.0 g/l Columbia agar base
6013PYG MEDIUM (MODIFIED) (DSMZ Medium 104)yeshttps://mediadive.dsmz.de/medium/104Name: PYG MEDIUM (modified) (DSMZ Medium 104) Composition: Yeast extract 10.0 g/l Peptone 5.0 g/l Trypticase peptone 5.0 g/l Beef extract 5.0 g/l Glucose 5.0 g/l L-Cysteine HCl x H2O 0.5 g/l NaHCO3 0.4 g/l NaCl 0.08 g/l K2HPO4 0.04 g/l KH2PO4 0.04 g/l MgSO4 x 7 H2O 0.02 g/l CaCl2 x 2 H2O 0.01 g/l Hemin 0.005 g/l Ethanol 0.0038 g/l Resazurin 0.001 g/l Tween 80 Vitamin K1 NaOH Distilled water
35308MEDIUM 20 - for Anaerobic bacteriayesAgar (15.000 g);Glucose (5.000 g);Yeast extract (20.000 g);Tryptone (30.000 g);Cysteine hydrochloride (0.500 g);distilled water (1000.000 ml);Hemin solution -M00149 (25.000 ml)
121367CIP Medium 45yeshttps://catalogue-crbip.pasteur.fr/fiche_milieu.xhtml?crbip=45
121367CIP Medium 20yeshttps://catalogue-crbip.pasteur.fr/fiche_milieu.xhtml?crbip=20

culture temp

@refgrowthtypetemperaturerange
6013positivegrowth37mesophilic
35308positivegrowth37mesophilic
67770positivegrowth37mesophilic

Physiology and metabolism

oxygen tolerance

@refoxygen toleranceconfidence
6013anaerobe
69480anaerobe99.612
121367anaerobe

spore formation

  • @ref: 69480
  • spore formation: no
  • confidence: 99.99

metabolite utilization

@refmetaboliteutilization activitykind of utilization testedChebi-ID
68371Potassium 5-ketogluconate-builds acid from
68371Potassium 2-ketogluconate-builds acid from
68371gluconate-builds acid from24265
68371L-arabitol-builds acid from18403
68371D-arabitol-builds acid from18333
68371L-fucose-builds acid from18287
68371D-fucose-builds acid from28847
68371D-tagatose-builds acid from16443
68371D-lyxose-builds acid from62318
68371turanose-builds acid from32528
68371gentiobiose-builds acid from28066
68371xylitol-builds acid from17151
68371glycogen-builds acid from28087
68371starch-builds acid from28017
68371raffinose-builds acid from16634
68371melezitose-builds acid from6731
68371inulin-builds acid from15443
68371trehalose-builds acid from27082
68371sucrose-builds acid from17992
68371melibiose-builds acid from28053
68371lactose-builds acid from17716
68371maltose-builds acid from17306
68371cellobiose-builds acid from17057
68371salicin-builds acid from17814
68371esculin-builds acid from4853
68371arbutin-builds acid from18305
68371amygdalin-builds acid from27613
68371N-acetylglucosamine-builds acid from59640
68371methyl alpha-D-glucopyranoside-builds acid from320061
68371methyl alpha-D-mannoside-builds acid from43943
68371D-sorbitol-builds acid from17924
68371D-mannitol-builds acid from16899
68371myo-inositol-builds acid from17268
68371galactitol-builds acid from16813
68371L-rhamnose-builds acid from62345
68371L-sorbose-builds acid from17266
68371D-mannose-builds acid from16024
68371D-fructose-builds acid from15824
68371D-glucose-builds acid from17634
68371D-galactose-builds acid from12936
68371methyl beta-D-xylopyranoside-builds acid from74863
68371ribitol-builds acid from15963
68371L-xylose-builds acid from65328
68371D-xylose-builds acid from65327
68371D-ribose-builds acid from16988
68371L-arabinose-builds acid from30849
68371D-arabinose-builds acid from17108
68371erythritol-builds acid from17113
68371glycerol-builds acid from17754
121367D-arabinose-degradation17108
121367D-fructose-degradation15824
121367D-glucose-degradation17634
121367D-xylose-degradation65327
121367cellobiose-degradation17057
121367lactose-degradation17716
121367maltose-degradation17306
121367salicin-degradation17814
121367sucrose-degradation17992
121367esculin-hydrolysis4853
121367nitrate-reduction17632
121367nitrite-reduction16301
121367nitrate+respiration17632
68380urea-hydrolysis16199
68380arginine-hydrolysis29016
68380D-mannose-fermentation16024
68380raffinose-fermentation16634
68380L-glutamate-degradation29985

metabolite production

  • @ref: 121367
  • Chebi-ID: 35581
  • metabolite: indole
  • production: yes

enzymes

@refvalueactivityec
68382alpha-fucosidase-3.2.1.51
68382alpha-mannosidase-3.2.1.24
68382N-acetyl-beta-glucosaminidase-3.2.1.52
68382beta-glucosidase-3.2.1.21
68382alpha-glucosidase+3.2.1.20
68382beta-glucuronidase-3.2.1.31
68382beta-galactosidase-3.2.1.23
68382alpha-galactosidase-3.2.1.22
68382naphthol-AS-BI-phosphohydrolase+
68382acid phosphatase+3.1.3.2
68382alpha-chymotrypsin-3.4.21.1
68382trypsin-3.4.21.4
68382cystine arylamidase-3.4.11.3
68382valine arylamidase-
68382leucine arylamidase+3.4.11.1
68382lipase (C 14)-
68382esterase lipase (C 8)+
68382esterase (C 4)+
68382alkaline phosphatase-3.1.3.1
68380serine arylamidase-
68380glutamyl-glutamate arylamidase-
68380histidine arylamidase-
68380glycin arylamidase-
68380alanine arylamidase-3.4.11.2
68380tyrosine arylamidase-
68380pyrrolidonyl arylamidase-3.4.19.3
68380leucine arylamidase-3.4.11.1
68380phenylalanine arylamidase-
68380leucyl glycin arylamidase-3.4.11.1
68380proline-arylamidase-3.4.11.5
68380L-arginine arylamidase-
68380alkaline phosphatase-3.1.3.1
68380alpha-fucosidase-3.2.1.51
68380glutamate decarboxylase-4.1.1.15
68380N-acetyl-beta-glucosaminidase-3.2.1.52
68380beta-glucuronidase-3.2.1.31
68380alpha-arabinosidase-3.2.1.55
68380beta-glucosidase-3.2.1.21
68380alpha-glucosidase-3.2.1.20
68380beta-Galactosidase 6-phosphate-
68380beta-galactosidase-3.2.1.23
68380alpha-galactosidase-3.2.1.22
68380arginine dihydrolase-3.5.3.6
68380urease-3.5.1.5
121367oxidase-
121367beta-galactosidase+3.2.1.23
121367alcohol dehydrogenase-1.1.1.1
121367gelatinase-
121367amylase-
121367DNase-
121367caseinase-3.4.21.50
121367catalase-1.11.1.6
121367tween esterase-
121367lecithinase+
121367lipase-
121367lysine decarboxylase-4.1.1.18
121367ornithine decarboxylase-4.1.1.17
121367protease+
121367urease-3.5.1.5

fatty acid profile

  • fatty acids

    @reffatty acidpercentageECL
    65615C12:00.712
    65615C14:029.414
    65615C15:00.915
    65615C16:01916
    65615C18:0218
    65615C13:0 3OH/C15:1 i I/H2.414.469
    65615C13:1 at 12-130.712.931
    65615C14:0 3OH/C16:1 ISO I5.415.485
    65615C16:0 3OH7.117.52
    65615C16:0 aldehyde1.714.949
    65615C16:1 ω7c8.115.819
    65615C16:1 ω7c DMA0.816.288
    65615C17:1 ISO I/C16:0 DMA6.716.481
    65615C18:1 ω7c /12t/9t1.917.824
    65615C18:1 ω9c5.317.769
    65615C18:2 ω6,9c/C18:0 ANTE817.724
  • type of FA analysis: whole cell analysis
  • method/protocol: CCUG

API zym

@refControlAlkaline phosphataseEsteraseEsterase LipaseLipaseLeucine arylamidaseValine arylamidaseCystine arylamidaseTrypsinalpha- ChymotrypsinAcid phosphataseNaphthol-AS-BI-phosphohydrolasealpha- Galactosidasebeta- Galactosidasebeta- Glucuronidasealpha- Glucosidasebeta- GlucosidaseN-acetyl-beta- glucosaminidasealpha- Mannosidasealpha- Fucosidase
121367--++-+----++---+----

API 50CHac

@refGLYERYDARALARARIBDXYLLXYLADOMDXGALGLUFRUMNESBERHADULINOMANSORMDMMDGNAGAMYARBESCSALCELMALLACMELSACTREINUMLZRAFAMDGLYGXLTGENTURLYXTAGDFUCLFUCDARLLARLGNT2KG5KG
121367-------------------------------------------------

API rID32A

@refUREADH Argalpha GALbeta GALbeta GPalpha GLUbeta GLUalpha ARAbeta GURbeta NAGMNERAFGDCalpha FUCNITINDPALArgAProALGAPheALeuAPyrATyrAAlaAGlyAHisAGGASerA
6013---------------+-------------
6013--------------+--------------
6013---------------+-------------
6013---------------+-------------
6013---------------+-------------
6013---------------+-------------
6013---------------+-------------
6013---------------+-------------
6013---------------+-------------
6013---------------+-------------

Isolation, sampling and environmental information

isolation

@refsample type
6013cervico-facial lesion
67770Cervico-facial lesion
121367Human, Cervico-facial lesion

isolation source categories

Cat1Cat2Cat3
#Host Body-Site#Oral cavity and airways#Throat
#Host Body-Site#Other#Wound

taxonmaps

  • @ref: 69479
  • File name: preview.99_1338.png
  • url: https://microbeatlas.org/index.html?action=taxon&taxon_id=90_140;96_436;97_498;98_572;99_1338&stattab=map
  • Last taxonomy: Fusobacterium nucleatum
  • 16S sequence: GQ301038
  • Sequence Identity:
  • Total samples: 3612
  • soil counts: 15
  • aquatic counts: 188
  • animal counts: 3393
  • plant counts: 16

Safety information

risk assessment

@refbiosafety levelbiosafety level comment
60132Risk group (German classification)
1213671Risk group (French classification)

Sequence information

16S sequences

@refdescriptionaccessionlengthdatabaseNCBI tax ID
20218Fusobacterium nucleatum subsp. nucleatum gene for 16S ribosomal RNA, partial sequence, strain: JCM 8532AB5730681481ena190304
20218Fusobacterium nucleatum subsp. nucleatum strain ATCC 25586 16S ribosomal RNA gene, partial sequence; internal transcribed spacer 1, complete sequence; and 23S ribosomal RNA gene, partial sequenceAF342829745ena190304
20218Fusobacterium nucleatum subsp. nucleatum 16S ribosomal RNA geneAJ1334961479ena190304
20218Fusobacterium nucleatum subsp. nucleatum strain ATCC 25586 16S ribosomal RNA gene, partial sequenceGQ3010381442ena190304
20218Fusobacterium nucleatum subsp. nucleatum ATCC 25586 clone C1_short_clone2 16S ribosomal RNA gene, partial sequence; 16S-23S ribosomal RNA intergenic spacer, complete sequence; and 23S ribosomal RNA gene, partial sequenceJQ7246601023ena190304
20218Fusobacterium nucleatum subsp. nucleatum ATCC 25586 clone C1_short_clone4 16S ribosomal RNA gene, partial sequence; 16S-23S ribosomal RNA intergenic spacer, complete sequence; and 23S ribosomal RNA gene, partial sequenceJQ7246611023ena190304
20218Fusobacterium nucleatum subsp. nucleatum ATCC 25586 clone C1_short_clone5 16S ribosomal RNA gene, partial sequence; 16S-23S ribosomal RNA intergenic spacer, complete sequence; and 23S ribosomal RNA gene, partial sequenceJQ7246621023ena190304
20218Fusobacterium nucleatum subsp. nucleatum ATCC 25586 clone A1_long_clone7 16S ribosomal RNA gene, partial sequence; 16S-23S ribosomal RNA intergenic spacer, complete sequence; and 23S ribosomal RNA gene, partial sequenceJQ7246631199ena190304
20218Fusobacterium nucleatum subsp. nucleatum ATCC 25586 clone C1_short_clone8 16S ribosomal RNA gene, partial sequence; 16S-23S ribosomal RNA intergenic spacer, complete sequence; and 23S ribosomal RNA gene, partial sequenceJQ7246641023ena190304
20218Fusobacterium nucleatum subsp. nucleatum ATCC 25586 clone C1_short_clone13 16S ribosomal RNA gene, partial sequence; 16S-23S ribosomal RNA intergenic spacer, complete sequence; and 23S ribosomal RNA gene, partial sequenceJQ7246651023ena190304
20218Fusobacterium nucleatum subsp. nucleatum ATCC 25586 clone C1_short_clone14 16S ribosomal RNA gene, partial sequence; 16S-23S ribosomal RNA intergenic spacer, complete sequence; and 23S ribosomal RNA gene, partial sequenceJQ7246661022ena190304
20218Fusobacterium nucleatum subsp. nucleatum ATCC 25586 clone C1_short_clone15 16S ribosomal RNA gene, partial sequence; 16S-23S ribosomal RNA intergenic spacer, complete sequence; and 23S ribosomal RNA gene, partial sequenceJQ7246671023ena190304
20218Fusobacterium nucleatum subsp. nucleatum ATCC 25586 clone A1_long_clone16 16S ribosomal RNA gene, partial sequence; 16S-23S ribosomal RNA intergenic spacer, complete sequence; and 23S ribosomal RNA gene, partial sequenceJQ7246681200ena190304
20218Fusobacterium nucleatum subsp. nucleatum ATCC 25586 clone C1_short_clone17 16S ribosomal RNA gene, partial sequence; 16S-23S ribosomal RNA intergenic spacer, complete sequence; and 23S ribosomal RNA gene, partial sequenceJQ7246691023ena190304
20218Fusobacterium nucleatum subsp. nucleatum small subunit ribosomal RNA gene sequenceM586831522ena190304
20218Fusobacterium nucleatum subsp. nucleatum small subunit ribosomal RNAX554011331ena190304
6013Fusobacterium nucleatum subsp. nucleatum ATCC 25586, section 65 of 197 of the complete genomeAE01052311396ena190304

Genome sequences

@refdescriptionaccessionassembly leveldatabaseNCBI tax ID
66792Fusobacterium nucleatum subsp. nucleatum ATCC 25586GCA_000007325completencbi190304
66792Fusobacterium nucleatum subsp. nucleatum ATCC 25586190304.8completepatric190304
66792Fusobacterium nucleatum nucleatum ATCC 25586637000117completeimg190304

Genome-based predictions

predictions

traitpredictionconfidencetraining_data
spore-formingyes80no
motileno92.065no
flagellatedno95.373no
gram-positiveno92.793no
anaerobicyes99.578yes
halophileno72.118no
spore-formingno89.148no
glucose-utilyes81.822no
aerobicno98.745no
thermophileno98.178no
glucose-fermentyes59.372no

External links

@ref: 6013

culture collection no.: DSM 15643, ATCC 25586, CCUG 32989, CIP 101130, JCM 8532, LMG 13131, VPI 4355, BCRC 10681, CCUG 33059, KCTC 2640

straininfo link

  • @ref: 75244
  • straininfo: 92417

literature

topicPubmed-IDtitleauthorsjournalDOIyearmeshtopic2
Phylogeny2223601Proposal of three subspecies of Fusobacterium nucleatum Knorr 1922: Fusobacterium nucleatum subsp. nucleatum subsp. nov., comb. nov.; Fusobacterium nucleatum subsp. polymorphum subsp. nov., nom. rev., comb. nov.; and Fusobacterium nucleatum subsp. vincentii subsp. nov., nom. rev., comb. nov.Dzink JL, Sheenan MT, Socransky SSInt J Syst Bacteriol10.1099/00207713-40-1-741990Bacterial Proteins/analysis, DNA, Bacterial/genetics, Electrophoresis, Polyacrylamide Gel, Fusobacterium/analysis/*classification/genetics, Nucleic Acid Hybridization, Sequence Homology, Nucleic Acid, Species SpecificityEnzymology
Metabolism2323539Diisopropylfluorophosphate-binding proteins in the outer membrane of Fusobacterium nucleatum: strain variations.Brokstad KA, Bakken V, Vasstrand EN, Jensen HBFEMS Microbiol Lett10.1016/0378-1097(90)90289-31990Bacterial Outer Membrane Proteins/*metabolism, Fusobacterium/*metabolism, Isoflurophate/*metabolism, Molecular Weight, Species SpecificityPhylogeny
Cultivation2349450Growth conditions and outer membrane proteins of Fusobacterium nucleatum.Bakken V, Hogh BT, Jensen HBScand J Dent Res10.1111/j.1600-0722.1990.tb00964.x1990Autoradiography, Bacterial Outer Membrane Proteins/*analysis/biosynthesis, Culture Media, Electrophoresis, Polyacrylamide Gel, Fusobacterium/*growth & developmentEnzymology
Enzymology2636259Purification and partial characterization of a major outer-membrane protein of Fusobacterium nucleatum.Bakken V, Aaro S, Jensen HBJ Gen Microbiol10.1099/00221287-135-12-32531989Amino Acid Sequence, Amino Acids/analysis, Bacterial Outer Membrane Proteins/immunology/*isolation & purification, Chromatography, Gel, Cross Reactions, Electrophoresis, Polyacrylamide Gel, Fusobacterium/*analysis/immunology, Molecular Sequence Data, Molecular WeightGenetics
Enzymology2643582Structural analysis of lipopolysaccharides from Eikenella corrodens by use of murine monoclonal antibodies.Kato T, Takazoe I, Okuda KInfect Immun10.1128/iai.57.2.656-659.19891989Animals, *Antibodies, Monoclonal, Antigen-Antibody Reactions, Antigens, Bacterial/immunology/*isolation & purification, Bacteroides/*immunology, Carbohydrate Conformation, Eikenella corrodens/*immunology, Female, Lipopolysaccharides/immunology/*isolation & purification, Mice, Mice, Inbred BALB CPhylogeny
Phylogeny3818097Production of monoclonal antibodies that recognize specific and cross-reactive antigens of Fusobacterium nucleatum.Bird PS, Seymour GJInfect Immun10.1128/iai.55.3.771-777.19871987Animals, Antibodies, Bacterial/*immunology, Antibodies, Monoclonal/*immunology, Antigens, Bacterial/immunology, Cross Reactions, Enzyme-Linked Immunosorbent Assay, Fusobacterium/*immunology, Hybridomas, Mice, Mice, Inbred BALB C, Species SpecificityBiotechnology
Phylogeny6735473Immunoglobulin G response to subgingival gram-negative bacteria in human subjects.Naito Y, Okuda K, Takazoe IInfect Immun10.1128/iai.45.1.47-51.19841984Adult, *Antibody Formation, Bacteroides/immunology, Enzyme-Linked Immunosorbent Assay, Fusobacterium/immunology, Gingiva/*microbiology, Gram-Negative Bacteria/*immunology/isolation & purification, Humans, Immunoglobulin G/*analysis, Periodontitis/*microbiology, Reference Values, Species SpecificityPathogenicity
Metabolism6811551Pathway of lysine degradation in Fusobacterium nucleatum.Barker HA, Kahn JM, Hedrick LJ Bacteriol10.1128/jb.152.1.201-207.19821982Acetates/metabolism, Amino Acid Isomerases/metabolism, Amino Acid Oxidoreductases/metabolism, Ammonia-Lyases/metabolism, Butyrates/metabolism, Fermentation, Fusobacterium/enzymology/*metabolism, *Intramolecular Transferases, Lysine/*metabolism, Oxo-Acid-Lyases/metabolismEnzymology
Pathogenicity7560233Effect of periodontal treatments on serum IgG antibody titers against periodontopathic bacteria.Horibe M, Watanabe H, Ishikawa IJ Clin Periodontol10.1111/j.1600-051x.1995.tb00798.x1995Adult, Aggregatibacter actinomycetemcomitans/immunology, Alveolar Bone Loss/microbiology/surgery/therapy, Antibodies, Bacterial/*blood, Bacteria/*immunology, Capnocytophaga/immunology, Dental Scaling, Eikenella corrodens/immunology, Female, Fusobacterium nucleatum/immunology, Humans, Immunoglobulin G/*blood, Male, Middle Aged, Periodontal Pocket/microbiology/surgery/therapy, Periodontitis/*microbiology/surgery/*therapy, Porphyromonas gingivalis/immunology, Prevotella/immunology, Prevotella intermedia/immunology, Root Planing
Enzymology7588760The Fusobacterium nucleatum major outer-membrane protein (FomA) forms trimeric, water-filled channels in lipid bilayer membranes.Kleivdal H, Benz R, Jensen HBEur J Biochem10.1111/j.1432-1033.1995.310_1.x1995Bacterial Outer Membrane Proteins/*chemistry/isolation & purification, Cross-Linking Reagents, Diffusion, Electric Conductivity, Fusobacterium nucleatum/*chemistry, Ion Channels/*chemistry, Lipid Bilayers/*chemistry, Membrane Lipids/*chemistry, Molecular Structure, Porins/chemistry/isolation & purification, Protein Conformation, Water/chemistryPhylogeny
Enzymology7988882Sizing the Fusobacterium nucleatum genome by pulsed-field gel electrophoresis.Bolstad AIFEMS Microbiol Lett10.1111/j.1574-6968.1994.tb07214.x1994Chromosome Mapping, Electrophoresis, Gel, Pulsed-Field, Fusobacterium nucleatum/classification/*genetics, *Genome, Bacterial, Restriction MappingGenetics
Genetics8041356Sequence variability of the 40-kDa outer membrane proteins of Fusobacterium nucleatum strains and a model for the topology of the proteins.Bolstad AI, Tommassen J, Jensen HBMol Gen Genet10.1007/BF002801931994Amino Acid Sequence, Bacterial Outer Membrane Proteins/chemistry/*genetics, Base Sequence, DNA, Bacterial, Fusobacterium/*metabolism, Genetic Variation, Molecular Sequence Data, Protein Conformation, Sequence Homology, Amino AcidMetabolism
Metabolism8502161Methylation of adenine and cytosine in some strains of Fusobacterium nucleatum.Bolstad AI, Jensen HBMicrob Pathog10.1006/mpat.1993.10121993Adenine/*metabolism, Blotting, Southern, Cytosine/*metabolism, DNA, Bacterial/metabolism, Electrophoresis, Agar Gel, Fusobacterium nucleatum/*metabolism, Methylation, Polymerase Chain ReactionEnzymology
8941767Induction of systemic murine B-cell responses by Fusobacterium nucleatum and Porphyromonas gingivalis.Nunes IP, Jonsson R, Jensen HB, Bakken VOral Microbiol Immunol10.1111/j.1399-302x.1996.tb00349.x1996Animals, Antibodies, Bacterial/*biosynthesis/blood, Antigens, Bacterial/chemistry/*immunology, B-Lymphocytes/*immunology, Bacterial Outer Membrane Proteins/chemistry/immunology, Bacterial Proteins/chemistry/immunology, Ecosystem, Enzyme-Linked Immunosorbent Assay/methods, Female, Fusobacterium nucleatum/*immunology, Immunoblotting, Lymphocyte Activation, Mice, Mice, Inbred BALB C, Porphyromonas gingivalis/*immunology, Spleen/cytology/immunology, Statistics, Nonparametric
Pathogenicity8999284Extraction and characterization of the smooth-type lipopolysaccharide from Fusobacterium nucleatum JCM 8532 and its biological activities.Onoue S, Niwa M, Isshiki Y, Kawahara KMicrobiol Immunol10.1111/j.1348-0421.1996.tb01075.x1996Adult, Carbohydrates/analysis, Fibroblasts/pathology, Fusobacterium nucleatum/*chemistry, Gingivitis/etiology, Glucosamine/analogs & derivatives/analysis, Humans, Lipopolysaccharides/*chemistry/*isolation & purification/pharmacology, O Antigens/analysis/isolation & purification/pharmacology, Sugar Acids/analysisEnzymology
Enzymology9467390Arbitrarily primed polymerase chain reaction fingerprinting and clonal analysis of oral Fusobacterium nucleatum isolates.George KS, Reynolds MA, Falkler WA JrOral Microbiol Immunol10.1111/j.1399-302x.1997.tb00382.x1997Bacterial Typing Techniques, Clone Cells, DNA Fingerprinting/*methods, DNA Primers, DNA Restriction Enzymes, DNA, Bacterial/*analysis, Electrophoresis, Gel, Pulsed-Field, Evaluation Studies as Topic, Fusobacterium nucleatum/classification/*genetics/isolation & purification, Genotype, Humans, Mouth/microbiology, Periodontitis/microbiology, *Random Amplified Polymorphic DNA TechniquePhylogeny
Pathogenicity9835745[A comparative in-vitro study of the bactericidal efficacy of sodium hypochlorite and chlorhexidine gluconate plus cetrimide on root canal anaerobic bacterial flora].D'Arcangelo C, Varvara GMinerva Stomatol1998Anti-Bacterial Agents/*pharmacology, Bacteria, Anaerobic/*drug effects, Cetrimonium, Cetrimonium Compounds/*pharmacology, Chlorhexidine/*analogs & derivatives/pharmacology, Dental Pulp Cavity/*microbiology, Humans, Microbial Sensitivity Tests/methods/statistics & numerical data, Root Canal Irrigants/*pharmacology, Sodium Hypochlorite/*pharmacology, Time Factors
Pathogenicity10338189Abscess forming ability of streptococcus milleri group: synergistic effect with Fusobacterium nucleatum.Nagashima H, Takao A, Maeda NMicrobiol Immunol10.1111/j.1348-0421.1999.tb02395.x1999Abscess/*microbiology/pathology, Animals, Disease Models, Animal, Fusobacterium/*pathogenicity, Fusobacterium Infections/microbiology, Humans, Mice, Mice, Inbred BALB C, Phagocytosis, Streptococcal Infections/microbiology, Streptococcus/*pathogenicity
Pathogenicity11358538Kinetics of coaggregation of Porphyromonas gingivalis with Fusobacterium nucleatum using an automated microtiter plate assay.Metzger Z, Featherstone LG, Ambrose WW, Trope M, Arnold RROral Microbiol Immunol10.1034/j.1399-302x.2001.016003163.x2001Automation, Bacterial Adhesion/drug effects, *Bacteriological Techniques, Dose-Response Relationship, Drug, Fusobacterium nucleatum/classification/*cytology/drug effects, Galactose/administration & dosage/pharmacology, Humans, Kinetics, Porphyromonas gingivalis/classification/*cytology/drug effects, Sensitivity and Specificity, Statistics as Topic, TitrimetryEnzymology
Metabolism11889109Genome sequence and analysis of the oral bacterium Fusobacterium nucleatum strain ATCC 25586.Kapatral V, Anderson I, Ivanova N, Reznik G, Los T, Lykidis A, Bhattacharyya A, Bartman A, Gardner W, Grechkin G, Zhu L, Vasieva O, Chu L, Kogan Y, Chaga O, Goltsman E, Bernal A, Larsen N, D'Souza M, Walunas T, Pusch G, Haselkorn R, Fonstein M, Kyrpides N, Overbeek RJ Bacteriol10.1128/JB.184.7.2005-2018.20022002Amino Acids/metabolism, Bacterial Outer Membrane Proteins/metabolism, Biological Transport, Cell Division, Coenzymes/metabolism, DNA Repair, DNA Replication, DNA Transposable Elements, DNA, Bacterial/analysis, Drug Resistance, Bacterial, Fusobacterium nucleatum/*genetics/metabolism, *Genome, Bacterial, Lipid Metabolism, Lipopolysaccharides/metabolism, Mutagenesis, Insertional, Nucleotides/metabolism, *Protein Biosynthesis, Protons, Signal Transduction/physiology, *Transcription, Genetic, VirulenceGenetics
Pathogenicity11938715In vitro effect of intracanal medicaments on strict anaerobes by means of the broth dilution method.Rosa OP, Torres SA, Ferreira CM, Ferreira FBPesqui Odontol Bras10.1590/s1517-749120020001000062002Bacteria, Anaerobic/*drug effects, Indicator Dilution Techniques, Reproducibility of Results, Root Canal Therapy/*methods, Therapeutic Irrigation
Pathogenicity11985513Effect of Fusobacterium nucleatum on the T and B cell responses to Porphyromonas gingivalis in a mouse model.Gemmell E, Bird PS, Carter CL, Drysdale KE, Seymour GJClin Exp Immunol10.1046/j.1365-2249.2002.01852.x2002Animals, Antibodies, Bacterial/blood/immunology, Antibody Specificity, Antigens, Bacterial/immunology, B-Lymphocytes/*immunology, Bacteroidaceae Infections/blood/*immunology, Cross Reactions, Female, Fusobacterium Infections/blood/*immunology, Fusobacterium nucleatum/*immunology, Humans, Immunity, Mice, Mice, Inbred BALB C, Porphyromonas gingivalis/*immunology, T-Lymphocyte Subsets/*immunology
Pathogenicity12238802Activity of endodontic antibacterial agents against selected anaerobic bacteria.Ferreira CM, da Silva Rosa OP, Torres SA, Ferreira FB, Bernardinelli NBraz Dent J10.1590/s0103-644020020002000082002Bacteria, Anaerobic/*drug effects, Bacteroides fragilis/drug effects, Calcium Hydroxide/pharmacology, Camphor/pharmacology, Castor Oil/pharmacology, Chlorhexidine/*analogs & derivatives/pharmacology, Chlorophenols/pharmacology, Clostridium perfringens/drug effects, Culture Media, Detergents/pharmacology, Disinfectants/*pharmacology, Drug Combinations, Fusobacterium nucleatum/drug effects, Humans, Microbial Sensitivity Tests, Prevotella/drug effects, Root Canal Irrigants/*pharmacology, SpectrophotometryCultivation
Pathogenicity12479628In vitro effect of laser irradiation on cementum-bound endotoxin isolated from periodontally diseased roots.Liu CM, Shyu YC, Pei SC, Lan WH, Hou LTJ Periodontol10.1902/jop.2002.73.11.12602002Adult, Aggregatibacter actinomycetemcomitans/chemistry, Bacteroides/chemistry, Chi-Square Distribution, Dental Cementum/*microbiology, Endotoxins/*radiation effects, Humans, In Vitro Techniques, Interleukin-1/biosynthesis, *Laser Therapy, Limulus Test, Monocytes/metabolism, Neodymium, Periodontitis/*microbiology/*therapy, Porphyromonas gingivalis/chemistry, Statistics, Nonparametric, Treatment FailureMetabolism
Pathogenicity12636253Serum antibodies of periodontitis patients compared to the lipopolysaccharides of Porphyromonas gingivalis and Fusobacterium nucleatum.Onoue S, Imai T, Kumada H, Umemoto T, Kaca W, Isshiki Y, Kaneko A, Kawahara KMicrobiol Immunol10.1111/j.1348-0421.2003.tb02785.x2003Adult, Antibodies, Bacterial/*blood, Bacteroidaceae Infections/blood/*immunology/microbiology, Female, Fusobacterium Infections/blood/*immunology, Fusobacterium nucleatum/*immunology, Humans, Lipopolysaccharides/immunology, Male, Middle Aged, Periodontitis/blood/*immunology/microbiology, Porphyromonas gingivalis/*immunology
Metabolism12799352Genome analysis of F. nucleatum sub spp vincentii and its comparison with the genome of F. nucleatum ATCC 25586.Kapatral V, Ivanova N, Anderson I, Reznik G, Bhattacharyya A, Gardner WL, Mikhailova N, Lapidus A, Larsen N, D'Souza M, Walunas T, Haselkorn R, Overbeek R, Kyrpides NGenome Res10.1101/gr.5660032003ATP-Binding Cassette Transporters/metabolism, Amino Acids/biosynthesis, Bacterial Proteins/biosynthesis/metabolism, Bacteriophages/genetics, Carbon/metabolism, Cell Division/genetics, DNA Repair/genetics, DNA Replication/genetics, DNA Transposable Elements, Drug Resistance, Bacterial/genetics, Energy Metabolism/genetics, Fusobacterium nucleatum/enzymology/*genetics/metabolism/pathogenicity, *Genome, Bacterial, Heat-Shock Proteins, Lipids/biosynthesis, Lipopolysaccharides/chemistry/metabolism, Membrane Proteins/genetics, Peptide Biosynthesis/genetics, Peptide Hydrolases/metabolism, Phosphotransferases/metabolism, RNA, Bacterial/genetics, RNA, Ribosomal/genetics, RNA, Transfer/genetics, Signal Transduction/genetics, Species SpecificityGenetics
Metabolism15993836Protein secretion systems in Fusobacterium nucleatum: genomic identification of Type 4 piliation and complete Type V pathways brings new insight into mechanisms of pathogenesis.Desvaux M, Khan A, Beatson SA, Scott-Tucker A, Henderson IRBiochim Biophys Acta10.1016/j.bbamem.2005.05.0022005Amino Acid Motifs, Amino Acid Sequence, Bacterial Physiological Phenomena, Base Sequence, Biofilms, Computational Biology/methods, Fimbriae, Bacterial/*metabolism, Fusobacterium/metabolism, Fusobacterium nucleatum/*genetics/*pathogenicity, Molecular Sequence Data, Open Reading Frames, Phylogeny, Protein Binding, Protein Conformation, Protein Sorting Signals, Protein Structure, Secondary, Protein Structure, Tertiary, Protein Transport, Sequence Homology, Amino Acid, Software, VirulenceGenetics
Metabolism16030227Identification and characterization of a novel adhesin unique to oral fusobacteria.Han YW, Ikegami A, Rajanna C, Kawsar HI, Zhou Y, Li M, Sojar HT, Genco RJ, Kuramitsu HK, Deng CXJ Bacteriol10.1128/JB.187.15.5330-5340.20052005Adhesins, Bacterial/chemistry/genetics/*metabolism, Amino Acid Sequence, Animals, CHO Cells, Cell Line, Cricetinae, Fusobacterium nucleatum/genetics/growth & development/*metabolism, Gene Deletion, Humans, Molecular Sequence Data, Molecular Weight, Mutation, Sequence Alignment, Species SpecificityPathogenicity
Pathogenicity16125361Enhanced pathogenicity of Fusobacterium nucleatum adapted to oxidative stress.Silva VL, Diniz CG, Cara DC, Santos SG, Nicoli JR, Carvalho MA, Farias LMMicrob Pathog10.1016/j.micpath.2005.07.0022005*Adaptation, Physiological, Animals, Body Weight, Fusobacterium Infections/pathology, Fusobacterium nucleatum/growth & development/*pathogenicity/ultrastructure, Humans, Liver/pathology, Mice, Organ Size, *Oxidative Stress, Spleen/pathologyStress
Phylogeny16145547Development of strain-specific PCR primers based on a DNA probe Fu12 for the identification of fusobacterium nucleatum subsp. nucleatum ATCC 25586T.Kim HS, Song SK, Yoo SY, Jin DC, Shin HS, Lim CK, Kim MS, Kim JS, Choe SJ, Kook JKJ Microbiol22572005Blotting, Southern, DNA Probes/chemistry/*genetics, DNA, Bacterial/chemistry/genetics/isolation & purification, Fusobacterium Infections/microbiology, Fusobacterium nucleatum/*genetics/isolation & purification, Humans, Luminescent Measurements, Periodontitis/microbiology, Polymerase Chain Reaction/*methods, Sensitivity and Specificity, Sequence Analysis, DNA, Species SpecificityEnzymology
Pathogenicity16673792Antimicrobial effect in vitro of chlorhexidine and calcium hydroxide impregnated gutta-percha points.Bozza FL, Molgatini SL, Perez SB, Tejerina DP, Perez Tito RI, Kaplan AEActa Odontol Latinoam2005Anti-Infective Agents, Local/*pharmacology, Calcium Hydroxide/*pharmacology, Candida albicans/drug effects, Chlorhexidine/*pharmacology, Colony Count, Microbial, Culture Media, Enterococcus faecalis/drug effects, Fusobacterium nucleatum/drug effects, *Gutta-Percha, Humans, Hydrogen-Ion Concentration, Materials Testing, Oxygen, Porphyromonas gingivalis/drug effects, Prevotella intermedia/drug effects, *Root Canal Filling Materials, Staphylococcus aureus/drug effects, Streptococcus mutans/drug effects, Temperature, Time FactorsCultivation
Metabolism16806047Antimicrobial actions of benzimidazoles against the oral anaerobes Fusobacterium nucleatum and Prevotella intermedia.Sheng J, Nguyen PT, Baldeck JD, Olsson J, Marquis REArch Oral Biol10.1016/j.archoralbio.2006.05.00220062-Pyridinylmethylsulfinylbenzimidazoles/*pharmacology, Amino Acids/metabolism, Aminopeptidases/antagonists & inhibitors, Anaerobiosis/physiology, Anti-Infective Agents/*pharmacology, Enzyme Inhibitors/pharmacology, Fermentation, Fructose/metabolism, Fusobacterium nucleatum/*drug effects/metabolism, Glucose, Glutamic Acid/metabolism, Humans, Hydrogen-Ion Concentration, Lansoprazole, Lysine/metabolism, Mouth/*microbiology, Oxygen/metabolism, Prevotella intermedia/*drug effects/metabolism, Serine/metabolismPathogenicity
Metabolism17120973Effects of sonicated Prevotella intermedia, Fusobacterium nucleatum and Lactobacillus casei extracts on interleukin-8 production by human dental pulp cells.Thaweboon B, Thaweboon S, Choonharuangdej S, Suppakpatana PSoutheast Asian J Trop Med Public Health2006Adolescent, Adult, Bacterial Infections/*metabolism, Cell Survival, Cells, Cultured, Dental Pulp/metabolism/*microbiology, *Fusobacteria, Humans, Interleukin-8/*biosynthesis, *Lactobacillus casei, *Prevotella intermediaPathogenicity
Enzymology17584449Physiological alterations of a Fusobacterium nucleatum strain exposed to oxidative stress.da Silva VL, Diniz CG, dos Santos SG, Gomes RM, Nicoli JR, Magalhaes PP, Mendes EN, de Carvalho MA, Farias LMJ Appl Microbiol10.1111/j.1365-2672.2006.03236.x2007Adaptation, Physiological, Bacterial Proteins/metabolism, Bacterial Typing Techniques/methods, Electrophoresis, Gel, Two-Dimensional/methods, Fusobacterium nucleatum/classification/genetics/*physiology, Genetic Variation, Oxidative Stress/*physiology, Polymerase Chain Reaction/methodsStress
Pathogenicity18312575Interactions between salivary Bifidobacterium adolescentis and other oral bacteria: in vitro coaggregation and coadhesion assays.Nagaoka S, Hojo K, Murata S, Mori T, Ohshima T, Maeda NFEMS Microbiol Lett10.1111/j.1574-6968.2008.01092.x2008Bacteria/drug effects/genetics/isolation & purification, *Bacterial Adhesion/drug effects, *Bacterial Physiological Phenomena/drug effects, Bifidobacterium/drug effects/genetics/isolation & purification/*physiology, Biofilms/drug effects/growth & development, Endopeptidase K/pharmacology, Fusobacterium nucleatum/drug effects/genetics/physiology, Hot Temperature, Humans, In Situ Hybridization, Fluorescence, Mouth/*microbiology, Saliva/*microbiologyEnzymology
Metabolism18793368Stimulation of epithelial cell matrix metalloproteinase (MMP-2, -9, -13) and interleukin-8 secretion by fusobacteria.Gursoy UK, Kononen E, Uitto VJOral Microbiol Immunol10.1111/j.1399-302X.2008.00453.x2008Blotting, Western, Cell Line, Epithelial Cells, Fusobacterium/classification/*physiology, Fusobacterium necrophorum/physiology, Fusobacterium nucleatum/physiology, Humans, Interleukin-8/analysis/*metabolism, Keratinocytes/*enzymology/microbiology, Matrix Metalloproteinase 1/analysis/metabolism, Matrix Metalloproteinase 13/analysis/metabolism, Matrix Metalloproteinase 9/analysis/metabolism, Matrix Metalloproteinases/analysis/*metabolism, Mouth/microbiology, Time FactorsPathogenicity
Pathogenicity20350156Biofilm formation enhances the oxygen tolerance and invasiveness of Fusobacterium nucleatum in an oral mucosa culture model.Gursoy UK, Pollanen M, Kononen E, Uitto VJJ Periodontol10.1902/jop.2010.0906642010Aerobiosis/physiology, Bacterial Adhesion/physiology, Bacterial Physiological Phenomena, Biofilms/*growth & development, Cell Proliferation, Cell Survival, Collagen, Colony Count, Microbial, Coloring Agents, Epithelial Cells/microbiology, Fibroblasts/microbiology, Fusobacterium nucleatum/*physiology, Humans, Keratinocytes/microbiology, Ki-67 Antigen/analysis, L-Lactate Dehydrogenase/analysis, Microbial Viability, Mouth Mucosa/cytology/*microbiology, *Oxygen, Tissue Culture TechniquesEnzymology
Pathogenicity20380884Mixture of periodontopathogenic bacteria influences interaction with KB cells.Kirschbaum M, Schultze-Mosgau S, Pfister W, Eick SAnaerobe10.1016/j.anaerobe.2010.03.0092010*Bacterial Adhesion, Bacteroidetes/growth & development/*pathogenicity, Coculture Techniques, Epithelial Cells/immunology/*microbiology, Fusobacterium nucleatum/growth & development/*pathogenicity, Humans, Interleukins/*metabolism, KB Cells, Periodontal Diseases/*microbiology, Treponema denticola/growth & development/*pathogenicityMetabolism
Metabolism20413556Production of hydrogen sulfide by two enzymes associated with biosynthesis of homocysteine and lanthionine in Fusobacterium nucleatum subsp. nucleatum ATCC 25586.Yoshida Y, Ito S, Kamo M, Kezuka Y, Tamura H, Kunimatsu K, Kato HMicrobiology (Reading)10.1099/mic.0.039180-02010Alanine/*analogs & derivatives/biosynthesis, Ammonia/metabolism, Aspartate Aminotransferases/chemistry/genetics/*metabolism, Bacterial Proteins/chemistry/genetics/*metabolism, Cysteine Synthase/chemistry/genetics/*metabolism, Fusobacterium nucleatum/chemistry/enzymology/genetics/*metabolism, Homocysteine/*biosynthesis, Hydrogen Sulfide/*metabolism, Kinetics, Pyruvic Acid/metabolism, Substrate Specificity, SulfidesEnzymology
Metabolism20472741Production of indole from L-tryptophan and effects of these compounds on biofilm formation by Fusobacterium nucleatum ATCC 25586.Sasaki-Imamura T, Yano A, Yoshida YAppl Environ Microbiol10.1128/AEM.00166-102010Base Sequence, Biofilms/*drug effects/growth & development, Fusobacterium nucleatum/*drug effects/enzymology/*growth & development, Indoles/metabolism/*pharmacology, Molecular Sequence Data, Plankton/drug effects/growth & development, Recombinant Proteins/genetics/metabolism, Tryptophan/*metabolism/pharmacology, Tryptophanase/genetics/metabolismPathogenicity
Metabolism20847052Fusobacterium nucleatum-associated beta-defensin inducer (FAD-I): identification, isolation, and functional evaluation.Gupta S, Ghosh SK, Scott ME, Bainbridge B, Jiang B, Lamont RJ, McCormick TS, Weinberg AJ Biol Chem10.1074/jbc.M110.1331402010Bacterial Proteins/genetics/*isolation & purification/*metabolism, Blotting, Western, Cell Wall/metabolism, Cells, Cultured, Cloning, Molecular, Epithelial Cells/*metabolism, Fusobacterium Infections/genetics/*metabolism/microbiology, Fusobacterium nucleatum/genetics/isolation & purification, Gingiva/cytology/*metabolism, Humans, Immunity, Innate, Recombinant Proteins/genetics/*isolation & purification/*metabolism, Signal Transduction, Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization, Toll-Like Receptor 2, beta-Defensins/*metabolismEnzymology
Pathogenicity20849395Antimicrobial activity of sodium citrate against Streptococcus pneumoniae and several oral bacteria.Nagaoka S, Murata S, Kimura K, Mori T, Hojo KLett Appl Microbiol10.1111/j.1472-765X.2010.02932.x2010Anti-Bacterial Agents/*pharmacology, Bacteria/*drug effects/isolation & purification, Bacterial Infections/microbiology, Citrates/*pharmacology, Humans, Microbial Sensitivity Tests, Mouth Diseases/*microbiology, Pneumococcal Infections/*microbiology, Sodium Citrate, Streptococcus pneumoniae/*drug effects/isolation & purificationEnzymology
Metabolism21383473Myrsinoic acid B inhibits the production of hydrogen sulfide by periodontal pathogens in vitro.Ito S, Shimura S, Tanaka T, Yaegaki KJ Breath Res10.1088/1752-7155/4/2/0260052010Alkenes/*pharmacology, Benzofurans/*pharmacology, Chlorides/pharmacology, Enzyme Inhibitors/*pharmacology, Fusobacterium nucleatum/*metabolism, Humans, Hydrogen Sulfide/*metabolism, Porphyromonas gingivalis/*metabolism, Sulfhydryl Compounds/*metabolism, Treponema denticola/metabolism, Zinc Compounds/pharmacologyPathogenicity
Metabolism21493682Identification and enzymic analysis of a novel protein associated with production of hydrogen sulfide and L-serine from L-cysteine in Fusobacterium nucleatum subsp. nucleatum ATCC 25586.Yoshida Y, Suwabe K, Nagano K, Kezuka Y, Kato H, Yoshimura FMicrobiology (Reading)10.1099/mic.0.048934-02011Bacterial Proteins/genetics/*metabolism, Chromatography, Gas, Chromatography, High Pressure Liquid, Cysteine/*metabolism, Cysteine Synthase/genetics/metabolism, Escherichia coli/genetics/growth & development/metabolism, Fusobacterium nucleatum/enzymology/genetics/*metabolism, Hydrogen Sulfide/*metabolism, Kinetics, Serine/*biosynthesisEnzymology
Pathogenicity21692631A novel organotypic dento-epithelial culture model: effect of Fusobacterium nucleatum biofilm on B-defensin-2, -3, and LL-37 expression.Gursoy UK, Pollanen M, Kononen E, Uitto VJJ Periodontol10.1902/jop.2011.1101772011Antimicrobial Cationic Peptides/*biosynthesis, Biofilms/growth & development, Coculture Techniques, Epithelium/*metabolism, Fusobacterium nucleatum/*physiology, Humans, *Organ Culture Techniques, Tooth/cytology, beta-Defensins/*biosynthesisMetabolism
Metabolism21798982Identification of an L-methionine gamma-lyase involved in the production of hydrogen sulfide from L-cysteine in Fusobacterium nucleatum subsp. nucleatum ATCC 25586.Suwabe K, Yoshida Y, Nagano K, Yoshimura FMicrobiology (Reading)10.1099/mic.0.051813-02011Bacterial Proteins/chemistry/genetics/*metabolism, Carbon-Sulfur Lyases/chemistry/genetics/*metabolism, Cysteine/*metabolism, Fusobacterium nucleatum/chemistry/*enzymology/genetics/metabolism, Hydrogen Sulfide/*metabolism, KineticsEnzymology
Pathogenicity21945879Synergy in biofilm formation between Fusobacterium nucleatum and Prevotella species.Okuda T, Kokubu E, Kawana T, Saito A, Okuda K, Ishihara KAnaerobe10.1016/j.anaerobe.2011.09.0032011Amino Acids/pharmacology, Bacterial Adhesion/drug effects, Biofilms/drug effects/*growth & development, Carbohydrates/pharmacology, Chelating Agents/pharmacology, Coculture Techniques, Edetic Acid/pharmacology, Endopeptidase K/chemistry, Fusobacterium nucleatum/*physiology, Homoserine/analogs & derivatives/biosynthesis, Hot Temperature, Lactones, Prevotella/*physiology, Symbiosis/*physiologyStress
22203875In Vitro Antibacterial Activity of Galls of Quercus infectoria Olivier against Oral Pathogens.Basri DF, Tan LS, Shafiei Z, Zin NMEvid Based Complement Alternat Med10.1155/2012/6327962011
Pathogenicity22443519Human neutrophil defensins and their effect on epithelial cells.Gursoy UK, Kononen E, Luukkonen N, Uitto VJJ Periodontol10.1902/jop.2012.1200172012Adult, Anti-Infective Agents/analysis/*pharmacology, Bacterial Adhesion/drug effects, Basement Membrane/pathology, Cell Adhesion/drug effects, Cell Death/drug effects, Cell Movement/drug effects, Cell Proliferation/drug effects, Cell Survival/drug effects, Chronic Periodontitis/pathology, Coated Materials, Biocompatible/chemistry, Dose-Response Relationship, Drug, Epithelial Attachment/drug effects/pathology, Epithelial Cells/drug effects/pathology, Female, Fibronectins/chemistry, Fusobacterium nucleatum/drug effects, Gingiva/*drug effects/pathology, Gingival Pocket/pathology, Humans, Keratinocytes/drug effects, Male, Middle Aged, Neutrophils/*physiology, Prevotella intermedia/drug effects, alpha-Defensins/analysis/*pharmacology
Phylogeny22493171Fretibacterium fastidiosum gen. nov., sp. nov., isolated from the human oral cavity.Vartoukian SR, Downes J, Palmer RM, Wade WGInt J Syst Evol Microbiol10.1099/ijs.0.041038-02012Acetic Acid/metabolism, Bacteria/*classification/genetics/isolation & purification, Base Composition, Coculture Techniques, DNA, Bacterial/genetics, Fatty Acids/analysis, Humans, Molecular Sequence Data, Mouth/*microbiology, Periodontal Pocket/microbiology, *Phylogeny, Propionates/metabolism, RNA, Ribosomal, 16S/genetics, Sequence Analysis, DNAMetabolism
Pathogenicity23023263Morphological, biochemical, physiological and molecular aspects of the response of Fusobacterium nucleatum exposed to subinhibitory concentrations of antimicrobials.de Souza Filho JA, Diniz CG, Barbosa NB, de Freitas MC, Lopes Neves MS, da Gama Mazzei RN, Gameiro J, Coelho CM, da Silva VLAnaerobe10.1016/j.anaerobe.2012.09.0072012Anti-Bacterial Agents/*pharmacology, Bacterial Proteins/analysis, Bacterial Typing Techniques, Biofilms/drug effects/growth & development, Carbohydrate Metabolism/drug effects, Enzymes/metabolism, Fusobacterium nucleatum/cytology/*drug effects/genetics/physiology, Genotype, Microbial Sensitivity Tests, Polymorphism, Genetic, Proteome/analysisMetabolism
23049613Antibacterial Activity of Myristica fragrans against Oral Pathogens.Shafiei Z, Shuhairi NN, Md Fazly Shah Yap N, Harry Sibungkil CA, Latip JEvid Based Complement Alternat Med10.1155/2012/8253622012
Pathogenicity23404558Regulation of visfatin by microbial and biomechanical signals in PDL cells.Nogueira AV, Nokhbehsaim M, Eick S, Bourauel C, Jager A, Jepsen S, Cirelli JA, Deschner JClin Oral Investig10.1007/s00784-013-0935-12013Biomechanical Phenomena, Enzyme-Linked Immunosorbent Assay, Fusobacterium nucleatum/isolation & purification/pathogenicity, Humans, Nicotinamide Phosphoribosyltransferase/*metabolism, Periodontal Ligament/*cytology/metabolism/microbiology, Real-Time Polymerase Chain ReactionMetabolism
Pathogenicity24458367In vitro activity of Carvacrol against titanium-adherent oral biofilms and planktonic cultures.Ciandrini E, Campana R, Federici S, Manti A, Battistelli M, Falcieri E, Papa S, Baffone WClin Oral Investig10.1007/s00784-013-1179-92014Anti-Infective Agents/*pharmacology, Bacteria/classification/*drug effects, Bacterial Adhesion/drug effects, Biofilms/*drug effects, Cymenes, Flow Cytometry, In Vitro Techniques, Microbial Sensitivity Tests, Monoterpenes/*pharmacology, Plankton/*drug effects, *TitaniumPhylogeny
Metabolism24976684Biomechanical loading modulates proinflammatory and bone resorptive mediators in bacterial-stimulated PDL cells.Nogueira AV, Nokhbehsaim M, Eick S, Bourauel C, Jager A, Jepsen S, Rossa C Jr, Deschner J, Cirelli JAMediators Inflamm10.1155/2014/4254212014Cells, Cultured, Cyclooxygenase 2/metabolism, Dinoprostone/metabolism, Enzyme-Linked Immunosorbent Assay, Fusobacterium nucleatum/*pathogenicity, Humans, Osteoprotegerin/metabolism, Periodontal Ligament/cytology/*metabolism/*microbiology, RANK Ligand/metabolism, Reverse Transcriptase Polymerase Chain ReactionPathogenicity
Pathogenicity25132418Increased proliferation and decreased membrane permeability as defense mechanisms of Fusobacterium nucleatum against human neutrophilic peptide-1.Keskin M, Kononen E, Soderling E, Isik G, Firatli E, Uitto VJ, Gursoy UKAnaerobe10.1016/j.anaerobe.2014.08.0012014Biofilms/*growth & development, Cell Membrane/*physiology, Child, Female, Fusobacterium nucleatum/*drug effects/growth & development/metabolism/*physiology, Humans, Male, Middle Aged, *Permeability, Polysaccharides, Bacterial/metabolism, alpha-Defensins/*metabolismMetabolism
Pathogenicity25357190Identification and characterization of fusolisin, the Fusobacterium nucleatum autotransporter serine protease.Doron L, Coppenhagen-Glazer S, Ibrahim Y, Eini A, Naor R, Rosen G, Bachrach GPLoS One10.1371/journal.pone.01113292014Amino Acid Sequence, Bacterial Proteins/chemistry/*metabolism, Fusobacterium nucleatum/*enzymology/growth & development, Humans, Hydrolysis, Molecular Sequence Data, Molecular Weight, Proteolysis/drug effects, Sequence Alignment, Sequence Analysis, Protein, Serine Proteases/chemistry/*metabolism, Substrate Specificity/drug effects, Time Factors, Tosyl Compounds/pharmacology, Type V Secretion Systems/chemistry/*metabolismMetabolism
Pathogenicity25384405Essential oils and isolated compounds from Lippia alba leaves and flowers: antimicrobial activity and osteoclast apoptosis.Juiz PJ, Lucchese AM, Gambari R, Piva R, Penolazzi L, Di Ciano M, Uetanabaro AP, Silva F, Avila-Campos MJInt J Mol Med10.3892/ijmm.2014.19952014Anti-Infective Agents/chemistry/pharmacology, Apoptosis/drug effects, Cells, Cultured, Flowers/*chemistry, Humans, Lippia/*chemistry, Oils, Volatile/chemistry/*pharmacology, Osteoclasts/drug effects, Plant Extracts/chemistry/*pharmacology, Plant Leaves/*chemistry
Pathogenicity26347298Identification of an antibacterial protein by functional screening of a human oral metagenomic library.Arivaradarajan P, Warburton PJ, Paramasamy G, Nair SP, Allan E, Mullany PFEMS Microbiol Lett10.1093/femsle/fnv1422015Aldehyde Oxidoreductases/genetics, Amino Acid Sequence, Anti-Bacterial Agents/*chemistry/isolation & purification/pharmacology, Bacillus subtilis/drug effects, Bacteria/drug effects, Bacterial Proteins/*chemistry/isolation & purification/*pharmacology, Chromosomes, Artificial, Bacterial, Cloning, Molecular, Dental Plaque/*microbiology, Escherichia coli/genetics, Escherichia coli K12/drug effects, Genetic Vectors, Genomic Library, Humans, Lactobacillus casei/drug effects, *Metagenome, Molecular Sequence Data, Mutagenesis, Neisseria/*chemistry, Plasmids, Pseudomonas aeruginosa/drug effects, Saliva/*microbiology, Sequence Analysis, DNA, Staphylococcus aureus/drug effects, Staphylococcus epidermidis/drug effectsEnzymology
Biotechnology26538799The Effect of Bamboo Leaf Extract Solution and Sodium Copper Chlorophyllin Solution on Growth and Volatile Sulfur Compounds Production of Oral Malodor Associated Some Anaerobic Periodontal Bacteria.Majbauddin A, Kodani I, Ryoke KYonago Acta Med2015
Pathogenicity26923748Morphological and functional adaptations of Fusobacterium nucleatum exposed to human neutrophil Peptide-1.Musrati AA, Fteita D, Paranko J, Kononen E, Gursoy UKAnaerobe10.1016/j.anaerobe.2016.02.0082016*Adaptation, Physiological, Bacterial Adhesion, Biofilms/*drug effects/growth & development, Cell Membrane/*drug effects/metabolism/ultrastructure, Cell Membrane Permeability/drug effects, Cytoplasmic Granules/drug effects/metabolism/ultrastructure, Dose-Response Relationship, Drug, Fusobacterium Infections/microbiology, Fusobacterium nucleatum/*drug effects/isolation & purification/metabolism/ultrastructure, Humans, Microscopy, Electron, Transmission, Neutrophils/metabolism, Plankton/*drug effects/metabolism/ultrastructure, Recombinant Proteins/biosynthesis/pharmacology, alpha-Defensins/biosynthesis/*pharmacologyMetabolism
Metabolism26930710FAD-I, a Fusobacterium nucleatum Cell Wall-Associated Diacylated Lipoprotein That Mediates Human Beta Defensin 2 Induction through Toll-Like Receptor-1/2 (TLR-1/2) and TLR-2/6.Bhattacharyya S, Ghosh SK, Shokeen B, Eapan B, Lux R, Kiselar J, Nithianantham S, Young A, Pandiyan P, McCormick TS, Weinberg AInfect Immun10.1128/IAI.01311-152016Amino Acid Substitution, Anti-Infective Agents/metabolism, Bacterial Proteins/genetics/immunology/*metabolism, Cells, Cultured, Cysteine/genetics/metabolism, Diglycerides/metabolism, Epithelial Cells/immunology/microbiology, Escherichia coli/genetics/metabolism, Fusobacterium nucleatum/*immunology, Humans, Protein Biosynthesis, Protein Multimerization, Protein Processing, Post-Translational, RNA, Messenger/biosynthesis, Recombinant Proteins/genetics/immunology/metabolism, Toll-Like Receptor 1/*metabolism, Toll-Like Receptor 2/*metabolism, Toll-Like Receptor 6/*metabolism, Transcription, Genetic, Transcriptional Activation, beta-Defensins/*biosynthesisPathogenicity
27032997A dual-species microbial model for studying the dynamics between oral streptococci and periodontal pathogens during biofilm development on titanium surfaces by flow cytometry.Manti A, Ciandrini E, Campana R, Dominici S, Ciacci C, Federici S, Sisti D, Rocchi MB, Papa S, Baffone WRes Microbiol10.1016/j.resmic.2016.03.0042016Biofilms/*growth & development, Enzyme-Linked Immunosorbent Assay, Flow Cytometry, Fusobacterium nucleatum/growth & development/*physiology, Gentian Violet/analysis, *Microbial Interactions, Mouth/*microbiology, Porphyromonas gingivalis/growth & development/*physiology, Staining and Labeling, Streptococcus/growth & development/*physiology, *Titanium
Enzymology27118478Copaifera reticulata oleoresin: Chemical characterization and antibacterial properties against oral pathogens.Bardaji DK, da Silva JJ, Bianchi TC, de Souza Eugenio D, de Oliveira PF, Leandro LF, Rogez HL, Venezianni RC, Ambrosio SR, Tavares DC, Bastos JK, Martins CHAnaerobe10.1016/j.anaerobe.2016.04.0172016Anti-Bacterial Agents/chemistry/isolation & purification/*pharmacology, Bridged Bicyclo Compounds/isolation & purification, Cell Line, Cell Survival/drug effects, Dental Caries/microbiology, Fabaceae/*chemistry, Fibroblasts/cytology/drug effects, Humans, Lactobacillus casei/drug effects/growth & development/isolation & purification, Microbial Sensitivity Tests, Monocyclic Sesquiterpenes, Periodontitis/microbiology, Plant Extracts/chemistry/isolation & purification/*pharmacology, Porphyromonas gingivalis/*drug effects/growth & development/isolation & purification, Prevotella nigrescens/*drug effects/growth & development/isolation & purification, Sesquiterpenes/isolation & purification, Streptococcus mutans/drug effects/growth & development/isolation & purification, Streptococcus salivarius/drug effects/growth & development/isolation & purification, Terpenes/isolation & purificationPhylogeny
Metabolism27613803Discovery and characterization of de novo sialic acid biosynthesis in the phylum Fusobacterium.Lewis AL, Robinson LS, Agarwal K, Lewis WGGlycobiology10.1093/glycob/cww0682016Chromatography, High Pressure Liquid, Fusobacterium/*metabolism, Mass Spectrometry, N-Acetylneuraminic Acid/*biosynthesis/chemistry
Phylogeny27722787Bacterial invasion into radicular dentine-an in vitro study.Stauffacher S, Lussi A, Nietzsche S, Neuhaus KW, Eick SClin Oral Investig10.1007/s00784-016-1960-72016Actinomyces/isolation & purification, Bacterial Load, Coculture Techniques, Dental Pulp Cavity/*microbiology, Dentin/*microbiology, Fusobacterium nucleatum/isolation & purification, Humans, In Vitro Techniques, Microscopy, Electron, Scanning, Porphyromonas gingivalis/isolation & purification, Prevotella intermedia/isolation & purification, Species Specificity, Streptococcus gordonii/isolation & purification, Streptococcus sanguis/isolation & purificationEnzymology
Pathogenicity27762731Strain-Specific Impact of Fusobacterium nucleatum on Neutrophil Function.Kurgan S, Kansal S, Nguyen D, Stephens D, Koroneos Y, Hasturk H, Van Dyke TE, Kantarci AJ Periodontol10.1902/jop.2016.1602122016Apoptosis, Biofilms, Cell Differentiation, Cell Line, Cells, Cultured, Cytokines/metabolism, Flow Cytometry, Fusobacterium nucleatum/*physiology, Host-Pathogen Interactions, Humans, Neutrophils/metabolism/*physiology, Phagocytosis/*physiology, Real-Time Polymerase Chain ReactionMetabolism
Proteome28154519Mining the Proteome of Fusobacterium nucleatum subsp. nucleatum ATCC 25586 for Potential Therapeutics Discovery: An In Silico Approach.Habib AM, Islam MS, Sohel M, Mazumder MH, Sikder MO, Shahik SMGenomics Inform10.5808/GI.2016.14.4.2552016
Enzymology29021252A chemical and biological toolbox for Type Vd secretion: Characterization of the phospholipase A1 autotransporter FplA from Fusobacterium nucleatum.Casasanta MA, Yoo CC, Smith HB, Duncan AJ, Cochrane K, Varano AC, Allen-Vercoe E, Slade DJJ Biol Chem10.1074/jbc.M117.8191442017Bacterial Proteins, Fusobacterium nucleatum/*enzymology/pathogenicity, Membrane Proteins, Phosphatidylinositols, Phospholipases A1/*chemistry/metabolism/physiology, Type V Secretion Systems/*chemistry, VirulenceMetabolism
Metabolism29343611Structural insights into the catalytic mechanism of cysteine (hydroxyl) lyase from the hydrogen sulfide-producing oral pathogen, Fusobacterium nucleatum.Kezuka Y, Ishida T, Yoshida Y, Nonaka TBiochem J10.1042/BCJ201708382018Catalysis, Catalytic Domain, Crystallography, X-Ray, Cysteine/*chemistry/metabolism, Cysteine Synthase/*chemistry/genetics/metabolism, Fusobacterium nucleatum/*enzymology/pathogenicity, Humans, Hydrogen Sulfide/chemistry/metabolism, Hydroxyl Radical/chemistry, Kinetics, Models, Molecular, *Protein Conformation, Schiff Bases/chemistryEnzymology
Cultivation29364345Two mechanisms of oral malodor inhibition by zinc ions.Suzuki N, Nakano Y, Watanabe T, Yoneda M, Hirofuji T, Hanioka TJ Appl Oral Sci10.1590/1678-7757-2017-01612018Acetates/chemistry, Anti-Bacterial Agents/chemistry/*pharmacology, Bacteria/drug effects/growth & development, Chlorides/chemistry, Culture Media, Halitosis/*drug therapy/microbiology, Hydrogen Sulfide/analysis/*antagonists & inhibitors/chemistry/metabolism, Microbial Sensitivity Tests, Reproducibility of Results, Statistics, Nonparametric, Time Factors, Volatilization, Zinc/chemistry/*pharmacologyPathogenicity
Genetics29976645Fusobacterium Genomics Using MinION and Illumina Sequencing Enables Genome Completion and Correction.Todd SM, Settlage RE, Lahmers KK, Slade DJmSphere10.1128/mSphere.00269-182018Computational Biology/*methods, Fusobacterium nucleatum/*genetics, *Genome, Bacterial, Sequence Analysis, DNA/*methods, Whole Genome Sequencing/*methodsTranscriptome
30356383Antimicrobial Activity of Piper marginatum Jacq and Ilex guayusa Loes on Microorganisms Associated with Periodontal Disease.Gamboa F, Munoz CC, Numpaque G, Sequeda-Castaneda LG, Gutierrez SJ, Tellez NInt J Microbiol10.1155/2018/41473832018
Phylogeny31501282Utilizing Whole Fusobacterium Genomes To Identify, Correct, and Characterize Potential Virulence Protein Families.Umana A, Sanders BE, Yoo CC, Casasanta MA, Udayasuryan B, Verbridge SS, Slade DJJ Bacteriol10.1128/JB.00273-192019Adhesins, Bacterial/classification/*genetics/metabolism, Amino Acid Sequence, Bacterial Adhesion, Cell Line, Computational Biology/methods, Epithelial Cells/microbiology/pathology, Fusobacterium/classification/*genetics/metabolism/*pathogenicity, Fusobacterium Infections/microbiology/pathology, Gene Expression, *Genome, Bacterial, Gingiva/microbiology/pathology, HCT116 Cells, Humans, Phylogeny, Sequence Alignment, Sequence Homology, Amino Acid, Type V Secretion Systems/classification/*genetics/metabolism, Virulence, Virulence Factors/classification/*genetics/metabolismMetabolism
32259029Pleural fluid penetration of moxifloxacin and doripenem: An experimental model of empyema.Calik M, Calik SG, Dagli M, Kesli R, Esme HNorth Clin Istanb10.14744/nci.2019.059022019
Metabolism32271108Protocol of proceedings with Fusobacterium nucleatum and optimization of ABTS method for detection of reactive oxygen species.Kedziora A, Lesiow MK, Krupa K, Korzeniowska-Kowal A, Adamski R, Komarnicka UK, Stokowa-Soltys K, Bugla-Ploskonska G, Jezowska-Bojczuk MFuture Microbiol10.2217/fmb-2019-00102020Benzothiazoles/chemistry, Copper/pharmacology, Fusobacterium nucleatum/*chemistry/drug effects/*metabolism, Hydrogen Peroxide/pharmacology, Reactive Oxygen Species/*analysis/*metabolism, Spectrophotometry/*methods, Sulfonic Acids/chemistryPathogenicity
Pathogenicity32416351Thymoquinone inhibits biofilm formation and virulence properties of periodontal bacteria.Tantivitayakul P, Kaypetch R, Muadchiengka TArch Oral Biol10.1016/j.archoralbio.2020.1047442020*Benzoquinones/pharmacology, Biofilms, *Fusobacterium nucleatum/drug effects, *Porphyromonas gingivalis/drug effects, Virulence
Pathogenicity32549271New Pyrimidinone-Fused 1,4-Naphthoquinone Derivatives Inhibit the Growth of Drug Resistant Oral Bacteria.Kim K, Kim D, Lee H, Lee TH, Kim KY, Kim HBiomedicines10.3390/biomedicines80601602020
33088065Comparative evaluation of apical bacterial extrusion following root canal instrumentation using different endodontic file systems: An in vitro study.Vankayala B, Anantula K, Saladi H, Gudugunta L, Basavarajaiah JM, Yadav SSJ Conserv Dent10.4103/JCD.JCD_221_192020
Pathogenicity34259502Disruption of Metallostasis in the Anaerobic Human Pathogen Fusobacterium nucleatum by the Zinc Ionophore PBT2.Van Zuylen EM, Ferguson SA, Hughes A, Rennison D, Brimble MA, Cook GMACS Infect Dis10.1021/acsinfecdis.0c008872021Anaerobiosis, Biofilms, *Fusobacterium nucleatum, Humans, Ionophores, *Zinc
Transcriptome35085920Transcriptome analysis of Fusobacterium nucleatum reveals differential gene expression patterns in the biofilm versus planktonic cells.Zhao T, Chen J, Liu S, Yang J, Wu J, Miao L, Sun WBiochem Biophys Res Commun10.1016/j.bbrc.2021.11.0752022Bacterial Proteins/genetics/*metabolism, Biofilms/*growth & development, Fusobacterium nucleatum/genetics/*metabolism, Gene Expression Profiling, Gene Expression Regulation, Bacterial, Humans, Plankton/genetics/growth & development/*metabolism, *Transcriptome, VirulenceMetabolism
Metabolism35359716Fusobacterium nucleatum Accelerates Atherosclerosis via Macrophage-Driven Aberrant Proinflammatory Response and Lipid Metabolism.Zhou J, Liu L, Wu P, Zhao L, Wu YFront Microbiol10.3389/fmicb.2022.7986852022Pathogenicity
35505575A murine periodontitis model using coaggregation between human pathogens and a predominant mouse oral commensal bacterium.Liu M, Choi YJ Periodontal Implant Sci10.5051/jpis.21043602182022
35618163Chalcones with potential antibacterial and antibiofilm activities against periodontopathogenic bacteria.Satokata AAC, Souza JH, Silva LLO, Santiago MB, Ramos SB, Assis LR, Theodoro RDS, Oliveira LRE, Regasini LO, Martins CHGAnaerobe10.1016/j.anaerobe.2022.1025882022

Reference

@idauthorscataloguedoi/urltitlejournalpubmed
6013Curators of the DSMZLeibniz Institut DSMZ-Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH (DSM 15643)https://www.dsmz.de/collection/catalogue/details/culture/DSM-15643
20215Parte, A.C., Sardà Carbasse, J., Meier-Kolthoff, J.P., Reimer, L.C. and Göker, M.10.1099/ijsem.0.004332List of Prokaryotic names with Standing in Nomenclature (LPSN) moves to the DSMZ
20218Verslyppe, B., De Smet, W., De Baets, B., De Vos, P., Dawyndt P.10.1016/j.syapm.2013.11.002StrainInfo introduces electronic passports for microorganisms.Syst Appl Microbiol. 37: 42-50 201424321274
35308Curators of the CIPhttps://brclims.pasteur.fr/brcWeb/souche/detail/1/12672
65615Curators of the CCUGCulture Collection University of Gothenburg (CCUG) (CCUG 32989)https://www.ccug.se/strain?id=32989
66792Julia Koblitz, Joaquim Sardà, Lorenz Christian Reimer, Boyke Bunk, Jörg Overmannhttps://diaspora-project.de/progress.html#genomesAutomatically annotated for the DiASPora project (Digital Approaches for the Synthesis of Poorly Accessible Biodiversity Information)
67770Curators of the JCMhttps://jcm.brc.riken.jp/en/
68371Automatically annotated from API 50CH acid
68380Automatically annotated from API rID32A
68382Automatically annotated from API zym
69479João F Matias Rodrigues, Janko Tackmann,Gregor Rot, Thomas SB Schmidt, Lukas Malfertheiner, Mihai Danaila,Marija Dmitrijeva, Daniela Gaio, Nicolas Näpflin and Christian von Mering. University of Zurich.https://microbeatlas.org/MicrobeAtlas 1.0 beta
69480Julia Koblitz, Joaquim Sardà, Lorenz Christian Reimer, Boyke Bunk, Jörg Overmannhttps://diaspora-project.de/progress.html#genomesPredictions based on genome sequence made in the Diaspora project (Digital Approaches for the Synthesis of Poorly Accessible Biodiversity Information)
75244Reimer, L.C., Lissin, A.,Schober, I., Witte,J.F., Podstawka, A., Lüken, H., Bunk, B.,Overmann, J.10.60712/SI-ID92417.1StrainInfo: A central database for resolving microbial strain identifiers
121367Curators of the CIPCollection of Institut Pasteur (CIP 101130)https://catalogue-crbip.pasteur.fr/fiche_catalogue.xhtml?crbip=CIP%20101130